ADVENTRX Pharmaceuticals (ANX) Narrows Q1 Loss of 9c/Share

ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q1 EPS of ($0.09), versus ($0.13) reported last year.

For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• BMO starts chip stocks coverage: Here are its preferred picks